chrX-123888703-C-G

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2

The NM_001167.4(XIAP):​c.962C>G​(p.Ala321Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,207,692 control chromosomes in the GnomAD database, including 2 homozygotes. There are 74 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00020 ( 2 hom. 68 hem. )

Consequence

XIAP
NM_001167.4 missense

Scores

5
9
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.33

Publications

5 publications found
Variant links:
Genes affected
XIAP (HGNC:592): (X-linked inhibitor of apoptosis) This gene encodes a protein that belongs to a family of apoptotic suppressor proteins. Members of this family share a conserved motif termed, baculovirus IAP repeat, which is necessary for their anti-apoptotic function. This protein functions through binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 and inhibits apoptosis induced by menadione, a potent inducer of free radicals, and interleukin 1-beta converting enzyme. This protein also inhibits at least two members of the caspase family of cell-death proteases, caspase-3 and caspase-7. Mutations in this gene are the cause of X-linked lymphoproliferative syndrome. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 2 and 11.[provided by RefSeq, Feb 2011]
XIAP Gene-Disease associations (from GenCC):
  • X-linked lymphoproliferative disease due to XIAP deficiency
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant X-123888703-C-G is Benign according to our data. Variant chrX-123888703-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 367794.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000125 (14/112236) while in subpopulation EAS AF = 0.00309 (11/3565). AF 95% confidence interval is 0.00173. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XIAPNM_001167.4 linkc.962C>G p.Ala321Gly missense_variant Exon 3 of 7 ENST00000371199.8 NP_001158.2 P98170

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XIAPENST00000371199.8 linkc.962C>G p.Ala321Gly missense_variant Exon 3 of 7 1 NM_001167.4 ENSP00000360242.3 P98170

Frequencies

GnomAD3 genomes
AF:
0.000134
AC:
15
AN:
112184
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00336
Gnomad SAS
AF:
0.000360
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.000664
GnomAD2 exomes
AF:
0.000294
AC:
54
AN:
183430
AF XY:
0.000265
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00382
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000195
AC:
214
AN:
1095456
Hom.:
2
Cov.:
29
AF XY:
0.000188
AC XY:
68
AN XY:
360868
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26358
American (AMR)
AF:
0.00
AC:
0
AN:
35197
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19362
East Asian (EAS)
AF:
0.00696
AC:
210
AN:
30185
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54068
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40525
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4117
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
839635
Other (OTH)
AF:
0.0000869
AC:
4
AN:
46009
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
14
AN:
112236
Hom.:
0
Cov.:
23
AF XY:
0.000174
AC XY:
6
AN XY:
34418
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30965
American (AMR)
AF:
0.00
AC:
0
AN:
10473
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2658
East Asian (EAS)
AF:
0.00309
AC:
11
AN:
3565
South Asian (SAS)
AF:
0.000361
AC:
1
AN:
2770
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6127
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53256
Other (OTH)
AF:
0.000656
AC:
1
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.000140
ExAC
AF:
0.000329
AC:
40

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

X-linked lymphoproliferative disease due to XIAP deficiency Benign:2
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not specified Benign:1
May 04, 2022
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Benign
-0.085
T
BayesDel_noAF
Uncertain
0.11
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
T;T;T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D;.;.
M_CAP
Pathogenic
0.72
D
MetaRNN
Benign
0.025
T;T;T
MetaSVM
Uncertain
0.42
D
MutationAssessor
Pathogenic
3.0
M;M;M
PhyloP100
7.3
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-3.6
D;D;D
REVEL
Pathogenic
0.73
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.012
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.64
MVP
0.57
MPC
0.81
ClinPred
0.20
T
GERP RS
5.3
Varity_R
0.90
gMVP
0.66
Mutation Taster
=49/51
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.59
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.59
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs182340753; hg19: chrX-123022553; COSMIC: COSV109432424; API